People · Operator
Named in public records as an officer, director or promoter · active 2014–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Erytech Pharma | — | Biotechnology | Series B | $41.2M | $157.0M | 2014 |
Jerome BAILLY at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jerome BAILLY on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Luc Dochez | 1 | 4 |
| Pierre-Olivier GOINEAU | 1 | 1 |
| Yann GODFRIN | 1 | 1 |
| Philippe ARCHINARD | 1 | 1 |
| Gil BEYEN | 1 | 1 |
| Hilde WINDELS | 1 | 1 |
| SVEN ANDREASSON | 1 | 1 |
| ERIC SOYER | 1 | 1 |
| Martine GEORGE | 1 | 1 |
| J?r?me BAILLY | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.